Option Care Health’s (OPCH) Market Outperform Rating Reaffirmed at JMP Securities

Option Care Health (NASDAQ:OPCH)‘s stock had its “market outperform” rating restated by analysts at JMP Securities in a research report issued on Friday,Benzinga reports. They currently have a $30.00 price objective on the stock, down from their previous price objective of $31.00. JMP Securities’ price objective would indicate a potential upside of 23.66% from the company’s current price.

OPCH has been the topic of a number of other research reports. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. UBS Group started coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and dropped their price objective for the company from $38.00 to $26.00 in a report on Thursday, October 31st. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. Finally, Truist Financial dropped their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health has a consensus rating of “Hold” and a consensus target price of $29.14.

Option Care Health Trading Up 0.5 %

OPCH traded up $0.12 during mid-day trading on Friday, hitting $24.26. 274,018 shares of the stock were exchanged, compared to its average volume of 1,210,375. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a market cap of $4.13 billion, a PE ratio of 20.39, a PEG ratio of 2.43 and a beta of 1.31. The firm’s fifty day moving average is $23.10 and its two-hundred day moving average is $27.73. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Several institutional investors and hedge funds have recently made changes to their positions in the stock. FMR LLC increased its stake in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after purchasing an additional 4,304,896 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new stake in Option Care Health during the second quarter worth about $68,003,000. Victory Capital Management Inc. increased its stake in Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after acquiring an additional 1,585,818 shares during the last quarter. Magnetar Financial LLC increased its stake in Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after acquiring an additional 1,377,929 shares during the last quarter. Finally, Wellington Management Group LLP grew its stake in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after buying an additional 1,328,326 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.